BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11607818)

  • 21. Mechanism of leukemogenesis by the inv(16) chimeric gene CBFB/PEBP2B-MHY11.
    Shigesada K; van de Sluis B; Liu PP
    Oncogene; 2004 May; 23(24):4297-307. PubMed ID: 15156186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22).
    Sakai I; Tamura T; Narumi H; Uchida N; Yakushijin Y; Hato T; Fujita S; Yasukawa M
    Genes Chromosomes Cancer; 2005 Nov; 44(3):265-70. PubMed ID: 16015645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cancer and fusion gene].
    Nakata M; Ohki M
    Tanpakushitsu Kakusan Koso; 1997 Sep; 42(12):1978-90. PubMed ID: 9301327
    [No Abstract]   [Full Text] [Related]  

  • 24. The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor.
    Srinivasan RS; de Erkenez AC; Hemenway CS
    Oncogene; 2003 May; 22(22):3395-406. PubMed ID: 12776190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
    Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
    Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryptic chromosomal aberrations leading to an AML1/ETO rearrangement are frequently caused by small insertions.
    Gamerdinger U; Teigler-Schlegel A; Pils S; Bruch J; Viehmann S; Keller M; Jauch A; Harbott J
    Genes Chromosomes Cancer; 2003 Mar; 36(3):261-72. PubMed ID: 12557226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.
    Wang YY; Zhou GB; Yin T; Chen B; Shi JY; Liang WX; Jin XL; You JH; Yang G; Shen ZX; Chen J; Xiong SM; Chen GQ; Xu F; Liu YW; Chen Z; Chen SJ
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1104-9. PubMed ID: 15650049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of the AML1-ETO fusion transcript expression in children and young adults with t(8;21) acute myeloid leukemia.
    Fleischman EW; Baturina JA; Sokova OI; Popa AV; Kosorukova IS; Rowley JD
    Haematologica; 2003 Sep; 88(9):1078-9. PubMed ID: 12969821
    [No Abstract]   [Full Text] [Related]  

  • 29. Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO.
    Fliegauf M; Stock M; Berg T; Lübbert M
    Oncogene; 2004 Dec; 23(56):9070-81. PubMed ID: 15489901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts.
    Gozzini A; Rovida E; Dello Sbarba P; Galimberti S; Santini V
    Cancer Res; 2003 Dec; 63(24):8955-61. PubMed ID: 14695213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetics of acute myeloid leukaemia.
    Dash A; Gilliland DG
    Best Pract Res Clin Haematol; 2001 Mar; 14(1):49-64. PubMed ID: 11355923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of differentiation by a PHD domain in the NUP98-PHF23 fusion protein.
    Reader JC; Leng Q; Rassool FV; Ning Y
    Leuk Res; 2010 Aug; 34(8):1094-7. PubMed ID: 20219246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.
    Engel ME; Hiebert SW
    Cancer Treat Res; 2010; 145():127-47. PubMed ID: 20306249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translocations, fusion genes, and acute leukemia.
    Saha V; Young BD; Freemont PS
    J Cell Biochem Suppl; 1998; 30-31():264-76. PubMed ID: 9893279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute myeloid leukemia.
    Löwenberg B; Downing JR; Burnett A
    N Engl J Med; 1999 Sep; 341(14):1051-62. PubMed ID: 10502596
    [No Abstract]   [Full Text] [Related]  

  • 36. The molecular biology of acute myeloid leukemia. Proto-oncogene expression and function in normal and neoplastic myeloid cells.
    Willman CL; Whittaker MH
    Clin Lab Med; 1990 Dec; 10(4):769-96. PubMed ID: 2176959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein.
    Yang G; Khalaf W; van de Locht L; Jansen JH; Gao M; Thompson MA; van der Reijden BA; Gutmann DH; Delwel R; Clapp DW; Hiebert SW
    Mol Cell Biol; 2005 Jul; 25(14):5869-79. PubMed ID: 15988004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosomal translocations in human cancer.
    Rabbitts TH
    Nature; 1994 Nov; 372(6502):143-9. PubMed ID: 7969446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromatin modifying activity of leukaemia associated fusion proteins.
    Di Croce L
    Hum Mol Genet; 2005 Apr; 14 Spec No 1():R77-84. PubMed ID: 15809276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The MYB proto-oncogene suppresses monocytic differentiation of acute myeloid leukemia cells via transcriptional activation of its target gene GFI1.
    Zhao L; Ye P; Gonda TJ
    Oncogene; 2014 Aug; 33(35):4442-9. PubMed ID: 24121275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.